Position in GH
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$205,153
-$35,795 QoQ
Shares Held
2,221
-5.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $17,208,750 across 18 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
6,365 | $3,350,790 | |
| 2 | TWST |
Twist Bioscience Corp
|
21,095 | $2,170,253 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
4,138 | $2,074,627 | |
| 4 | NTRA |
Natera, Inc.
|
6,205 | $1,684,347 | |
| 5 | VCYT |
Veracyte, Inc.
|
24,694 | $1,450,278 | |
| 6 | GRAL |
GRAIL, Inc.
|
20,078 | $1,370,725 | |
| 7 | DHR |
Danaher Corp /De/
|
7,015 | $1,336,217 | |
| 8 | ILMN |
Illumina, Inc.
|
3,154 | $554,567 |
All Filings in GH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,153 | 2,221 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $240,948 | 2,359 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||